Skip to main content

IOANNIS GRIVEAS

MD, PhD
  • Participation in the ESKD SUMMIT Milan 9- 10 May 2023 with commentary in the section Chronic Dialysis Catheters: When and how and a speech entitled AV circuit: my clinical experience.
  • Participation in the webinar “Individualizing SGLT2i therapy based on therapeutic indications”, with a speech “The new treatment in patients with CKD with or without type II diabetes” 13 April 2022.
  • Participation with a speech at the 20th Panhellenic Diabetes Congress “Artificial intelligence and the kidney: the example of diabetic nephropathy”, Athens 18-21 May 2022.
  • Participation with a speech and chair at the Croatian Nephrology Congress on “Hemoperfusion on chronic hemodialysis COVID patients” Zagreb 27-29.5.2022.
  • Participation with a speech at the Croatian Nephrology Congress on the topic "Clinical Aspects of Apheresis" Zagreb 27-29.5.2022
  • Participation with a speech at the 23rd Panhellenic Nephrology Congress on the topic "Parenteral Nutrition during Hemodialysis", Thessaloniki 1-5 June 2022.
  • Participation with a speech at the 23rd Panhellenic Nephrology Congress on the topic "Dialysis Solutions: New Therapeutic Options", Thessaloniki 1-5 June 2022.
  • Participation with a speech at the 23rd Panhellenic Nephrology Congress on the topic "Perineal Dialysis: a Smart Choice", Thessaloniki 1-5 June 2022.
  • Participation with a speech at the 23rd Panhellenic Nephrology Conference on “Clinical efficacy and safety of the first HIF-PH inhibitor” Thessaloniki 1-5 June 2022.
  • Participation as Chair in the 23rd Panhellenic Nephrology Conference in the lecture on “Postulata of Interventional Nephrology in Europe and Greece” Thessaloniki 1-5 June 2022.
  • Participation with speeches at the 14th Panhellenic Nephrology Nurses Conference on “The latest in hemodialysis membranes” and on “Inclusion or discontinuation of hemodialysis in an elderly patient”, Kavala 16-18 June 2022.
  • Participation with a speech at the 23rd Panhellenic Nephrology Conference on “Clinical efficacy and safety of the first HIF-PH inhibitor” Thessaloniki 1-5 June 2022.
  • Participation with a speech on “Heart Failure and other conditions” in the context of the cardiology two-day conference “Heart Failure and Comorbidities: Diagnostic Approach and Therapeutic Options”, Athens 16-17 September 2022.
  • Participation with a speech on “Challenges in the management of anemia of CKD” at the Nephrology Symposium 2022, Larissa 2-4 December 2022.
  • Participation with a speech on “Hormones whose action is localized in the intertubular space” at the 7th Annual Scientific Event of the Nephrology Department of Papageorgiou General Hospital, Thessaloniki 9-11 December 2022.
  • Page